About this event
Recently, the U.S. Congress enacted changes to the requirements for obtaining and maintaining a federal Drug Enforcement Administration registration that allows prescribing of controlled substances.
On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.
While that requirement is intended to ensure that prescribers are treating opioid addictions appropriately, it goes beyond Schedule II narcotics; prescribers may need additional education about overall substance use disorders, including alcohol.
Many primary care physicians are lacking in the education and awareness of their options in diagnosing and treating patients for substance use disorders, despite the fact that many options exist in this regard.
Who can attend:
Registration is limited to ISMS members, ISMIE and SEMPIC policyholders and their employed staff.
Presenter:
Kirk Moberg, M.D.
Registration is limited to ISMS members, ISMIE policyholders and their employed staff.
Learning objectives
At the conclusion of this activity, learners will be able to:
- Describe the neurobiology of the reward pathway and its role in addictive disorders.
- Summarize the diagnostic criteria for substance use disorders and gambling disorders as described in DSM-5.
- Review the steps of screening and brief intervention for unhealthy use of alcohol and other substances.
Accreditation
The Illinois State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit designation
The Illinois State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure
There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.
